Nyxoah SA (NYXH:NASDAQ) closed at $0.856 on October 26, 2026, up 2.64% on the day. The stock trades 85.5% below its 52-week high of $5.92 and 7.1% above its 52-week low of $0.800. Over the past year, it lost 85.1%. Nyxoah SA is part of the Health Care sector.
In 252 trading sessions since October 24, 2025, NYXH closed higher on 107 days (42%). Its best day was September 3, 2026 (+16.56%) and its worst was June 5, 2026 (-49.65%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 3 times.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Find more stocks like NYXH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.